Cancer Prevention News

Medications intended to reduce risk for breast cancer should be offered to women with an elevated risk for the disease but a low risk for adverse events associated with these agents, according to a U.S. Preventive Services Task Force draft recommendation statement.

The overall rate of cancer deaths in the U.S. has declined by 27% during the past 25 years, with approximately 2.6 million fewer cancer deaths reported between 1991 and 2016, according to data from Cancer Statistics 2019, American Cancer Society’s annual report on cancer rates and trends.

The rate of women in the Upper Midwest who underwent cervical cancer screening in 2016 was lower than nationally reported rates, and researchers said this is “unacceptable,” according to a study recently published in the Journal of Women’s Health.

A new epigenetic test for cervical cancer demonstrated 100% accuracy, predicting development of the disease as many as 5 years in advance, according to a blinded case-control study published in International Journal of Cancer.

HIV-infected Hispanic adults in the United States demonstrated a higher risk for HPV-related cancers than Hispanics who did not have HIV, according to a study published in Cancer.

Showing an informational video on a digital tablet to parents of teenagers who were unvaccinated against HPV resulted in a threefold increase in their child’s likelihood of vaccination within 2 weeks, according to research published in Pediatrics.

Women positive for HPV16 or HPV18 but who do not have any cellular abnormalities remain at an increased risk for cervical cancer and its precursor lesions, according to results of a nested case-control study published in Cancer.

Swedish women with polycystic ovary syndrome are 15% more likely to develop any cancer vs. women without the condition, with risk further elevated for cancers of the endometrium, ovary, pancreas and kidney, according to a research letter published in JAMA Oncology.

Women aged 30 to 39 years with at least one of the three specific risk factors can benefit by starting screening at aged 30 instead of the recommended start of age 40 for average-risk women, according to a presenter at the Radiological Society of North America annual meeting.

Recently published trials offer more evidence to aid in physician decision-making regarding use of aspirin for primary prevention, according to a paper published in Annals of Internal Medicine.